See Master Service Agreement.
Glossary
MSA
02.27.12
-
Breaking News | Industry News
Revolo Biotherapeutics, CordenPharma Enter Master Service Agreement
Will scale up and manufacture ‘1104 for the treatment of eosinophilic esophagitis and allergic disease.Charles Sternberg, Assistant Editor
-
Breaking News | Drug Development | Industry News
Evotec Enters Master Service Agreement with Kazia Therapeutics
Will work together to make EVT801 available to patients globally.Charles Sternberg, Assistant Editor
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Asahi Kasei Pharma Contracts ProBioGen
Will use ProBioGen’s technologies for the advancement of its biologics pipeline.Contract Pharma Staff
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News | Process Development
ProBioGen, Heidelberg Pharma Ink ATAC Agreement
ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
